CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company, specializing in the extraction and conversion of cannabinoids. CLS stands for “Cannabis Life Sciences”, as it maintains a proprietary method of extracting various cannabinoids from the marijuana plant and converting them into higher quality and quantity. Several important events have led to the opportunity of a lifetime for Cannabis Cultivators and Industry Innovators. CLS Labs, Inc. is poised to make significant strides in the years to come.
For the past two years, Ray Keller, a shareholder of CLS, and a founder of CLS Labs has been developing a proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates such as oils, waxes, edibles and shatter.
These concentrates may be ingested in a number of ways, including through vaporization via electronic cigarettes and used for a variety of pharmaceutical and other purposes.
He has also created various delivery systems and materials to ready the converted cannabis product for different uses by different potential distributors. Mr. Keller contributed this intellectual property to CLS in exchange for stock in CLS. The proprietary process is patent pending, with a patent application having been led.
Read Full Profile: http://joom.ag/g19Q/p8